Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.61 |
| ▸ | IDO1 | P14902 | 1/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.57 |
| ▸ | MLKL | Q8NB16 | 2/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.54 |
| ▸ | POLB | P06746 | 1/20 | 0.54 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.54 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.49 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.49 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.49 |
| ▸ | ALPL | P05186 | 1/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.49 |
| ▸ | FPR1 | P21462 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL36603600 | 1.00 | KMT2A (0.61) | KMT2AIDO1SMN1; SMN2MLKLALDH1A1 | |
| SCHEMBL13803801 | 0.92 | IDO1 (0.61) | KMT2AIDO1SMN1; SMN2MLKLALDH1A1 | |
| SCHEMBL11586378 | 0.85 | IDO1 (0.57) | KMT2AIDO1SMN1; SMN2MLKLALDH1A1 | |
| SCHEMBL11021655 | 0.85 | IDO1 (0.57) | KMT2AIDO1SMN1; SMN2MLKLALDH1A1 | |
| SCHEMBL11021656 | 0.83 | IDO1 (0.59) | KMT2AIDO1SMN1; SMN2MLKLALDH1A1 | |
| SCHEMBL7485295 | 0.80 | ALDH1A1 (0.70) | KMT2AIDO1SMN1; SMN2MLKLALDH1A1 | |
| SCHEMBL10998993 | 0.80 | IDO1 (0.59) | KMT2AIDO1SMN1; SMN2MLKLALDH1A1 | |
| SCHEMBL5626297 | 0.80 | KMT2A (0.57) | KMT2AIDO1SMN1; SMN2MLKLALDH1A1 | |
| SCHEMBL10768298 | 0.80 | KMT2A (0.57) | KMT2AIDO1SMN1; SMN2MLKLALDH1A1 | |
| SCHEMBL28444260 | 0.80 | HPGD (0.69) | KMT2ASMN1; SMN2ALDH1A1POLBLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104725856-B | Conductive composition and the electric conductor and solid electrolytic capacitor of above-mentioned conductive composition are used | 三菱丽阳株式会社 | 2017-06-09 | — | — | CN | claimed |
| JP-57031617-A | — | — | None | — | — | JP | disclosed |
| CN-111781342-B | Sensitization type SPR immunosensor constructed by gold-magnetic composite nano-meter detects carbendazim | 中国医学科学院药用植物研究所 | 2023-07-07 | — | — | CN | disclosed |
| CN-116234548-A | Compounds comprising tricyclic parent nucleus as PD-1/PD-L1 blockers | 再生治疗有限公司 | 2023-06-06 | — | — | CN | disclosed |
| CN-111781342-A | Sensitization type SPR immunosensor constructed by gold-magnetic composite nano-particles for detecting carbendazim | 中国医学科学院药用植物研究所 | 2020-10-16 | — | — | CN | disclosed |
| CN-104718588-B | Conductive composition and solid electrolytic capacitor obtained using the same | 三菱化学株式会社 | 2018-08-28 | — | — | CN | disclosed |
| CN-105073884-B | Curable composition | LG化学株式会社 | 2018-01-30 | — | — | CN | disclosed |
| CN-104725856-B | Conductive composition and the electric conductor and solid electrolytic capacitor of above-mentioned conductive composition are used | 三菱丽阳株式会社 | 2017-06-09 | — | — | CN | disclosed |
| CN-104718588-A | Conductive composition and solid electrolytic capacitor obtained using the same | MITSUBISHI RAYON CO | 2015-06-17 | — | — | CN | disclosed |
| US-8470816-B2 | Nitrogen-containing heterocyclic compound and use thereof | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2013-06-25 | — | — | US | disclosed |
| WO-2007136635-A1 | ENHANCEMENT OF RADIATION THERAPY AND/OR CHEMOTHERAPY WITH ACID CERAMIDASE MODULATORS | MUSC FOUNDATION FOR RESEARCH DEVELOPMENT (US) | 2007-11-29 | — | — | WO | disclosed |
| WO-2007034252-A1 | AMINO-ALKYL-AMIDE DERIVATIVES AS CCR3 RECEPTOR LIQUIDS | SANOFI-AVENTIS (FR) | 2007-03-29 | — | — | WO | disclosed |
| WO-2006127550-A1 | PROLINE BIS-AMIDE OREXIN RECEPTOR ANTAGONISTS | MERCK & CO., INC. (US) | 2006-11-30 | — | — | WO | disclosed |
| US-6340696-B1 | ADMINISTERING THERAPEUTICALLY EFFECTIVE AMOUNT OF COMBINATION OF (5-ARYL-1,2,4-THIADIAZOL)-3-YL THIOUREA DERIVATIVE OR (5-ARYL-1,2,4-THIADIAZOL)-3-YL UREA DERIVATIVE AND RIBAVIRIN AND/OR INTERFERON | THE PROCTER & GAMBLE COMPANY | 2002-01-22 | — | — | US | disclosed |
| EP-0869787-A4 | VITRONECTIN RECEPTOR ANTAGONISTS | SMITHKLINE BEECHAM CORP (US) | 1999-03-24 | — | — | EP | disclosed |
| CN-1209744-A | Vitronectin receptor antagonists | SMITHKLINE BEECHAM CORP (US) | 1999-03-03 | — | — | CN | disclosed |
| EP-0869787-A1 | VITRONECTIN RECEPTOR ANTAGONISTS | SMITHKLINE BEECHAM CORPORATION (US) | 1998-10-14 | — | — | EP | disclosed |
| WO-1997024119-A1 | VITRONECTIN RECEPTOR ANTAGONISTS | SMITHKLINE BEECHAM CORPORATION (US) | 1997-07-10 | — | — | WO | disclosed |
| JP-S5731617-A | CARCINOSTATIC AGENT | NIPPON SHINYAKU CO LTD | 1982-02-20 | — | — | JP | disclosed |
| US-3987054-A | CORROSION INHIBITORS | PLIVA PHARMACEUTICAL AND CHEMICAL WORKS (YU) | 1976-10-19 | — | — | US | disclosed |